BioNet News 11 Apr 2025 New Research Boosts Future Whooping Cough Vaccines Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the… Pantitra
Biotech News 20 Feb 2025 Blood Test Predicts How Long Vaccines Will Protect You How long will vaccine protection last? A simple blood test may have the answer. Researchers at Stanford School of Medicine,… Pantitra
BioNet News 30 Dec 2024 Pertussis Immunity 5 Years After Booster Vaccination With Recombinant Pertussis Vaccines Pertussis remains one of the least controlled vaccine-preventable diseases. Pertussis booster vaccines are associated with fast-waning immunity and offer only… Pantitra
Biotech News 21 Nov 2024 Bolstering Pertussis Surveillance in Latin America As antimicrobial resistance (AMR) continues to pose a critical global health challenge, rising pertussis cases (whooping cough) and increasing evidence of macrolide-resistant Bordetella pertussis around the world… Pantitra
Biotech News 19 Nov 2024 Whooping cough vaccine urged for children The Ministry of Public Health is encouraging people, especially children and those in physical contact with them, to get vaccinated… Pantitra
Biotech News 19 Aug 2024 Whooping cough cases more than 3 times higher than last year in return to pre-pandemic levels More than 10,800 cases have been recorded this year so far Cases of whooping cough are more than three times higher this… Pantitra
BioNet News 30 Jul 2024 Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence Pertussis, caused by Bordetella pertussis, is a highly contagious respiratory disease that poses a significant risk to young infants, resulting in both severe morbidity… Pantitra
Biotech News 21 Jun 2024 Why are whooping cough infections surging in Australia and should you get a booster jab? Health experts say the rise is no surprise given the last pertussis epidemic was eight years ago, and urge people… Pantitra
BioNet News 12 Jan 2024 Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines Recombinant acellular pertussis (ap) vaccines containing genetically inactivated pertussis toxin (PTgen) and filamentous hemagglutinin (FHA) with or without tetanus (TT)… Pantitra
